top of page
2021 Slides
To view and download conference slides, please tap the presentation title. Not all presentations are available for download. 
FMC-21-07 DDNA Slide Icon.jpg
2021 Conference Slides
September 17–18, 2021

Cardiac Syndromes in Patients with Liver Disease  • Marc Klapholz, MD, MBA

Heartburn: Are There Any Modern Diagnoses for GERD (or Still the Old Ones?)  •  Prakash Gyawali, MD 

Esophageal Motility Disorders: An Overview  • Prakash Gyawali, MD 

New Advances Distinguished Lecturer 2021: Elimination of Viral Hepatitis  • Su Wang, MD, MPH, FACP

Update on Hepatitis B in 2021  • Kimberly Brown, MD 

Treatment Strategies for Hepatitis C  • Paul Kwo, MD 

Management of Patient with Compensated Cirrhosis  • Patrick Kamath, MD 


Pre-Transplant Evaluation: How to Proceed  • Michael Schilsky, MD 

Primary Biliary Cholangitis: New Treatment Options  •  Marlyn Mayo, MD 

Hepatic Encephalopathy: An Update on Diagnosis and Management  • Nancy Reau, MD 

Hepatorenal Syndrome:  To Treat or NOT to Treat? And How?  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA 

Wilson’s Disease Overview  • Michael Schilsky, MD 

Liver Cancer: Still an Evolving Field!  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA 

C. diffICULT (still!)  • Sushil Ahlawat, MD 


Colorectal Cancer Screening: How to Maximize the Potential  • Sushil Ahlawat, MD 


COVID-19 and Liver Disease: What Happened?  • Nancy Reau, MD 

To view and download conference slides, please tap the presentation title.
FMC-22-07 DDNA Slide Icon.jpg
2022 Conference Slides
September 16–17, 2022
2022 Slides

Hepatorenal Syndrome Treatment in the US Today  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA

Review of Eosinophilic Esophagitis  • Seyedehsan Navabi, MD

New Treatment Innovations in Ulcerative Colitis and Crohn’s Disease  • Stephen B. Hanauer, MD

New Advances in NASH in 2022  • David Kaplan, MD

Indeterminate Colitis: How to Approach?  • Farzana Rashid, MD

How to Increase the Adenoma Detection Rate  • Sushil Ahlawat, MD

New Advances Distinguished Lecturer 2022: Viral Hepatitis Elimination  • Rajender Reddy, MD


Hepatitis B Cure: New Drugs, Novel Strategies  • Jordan Feld, MD, MPH

Hepatitis C: What’s New? Is There Any Difficult to Treat Populations Nowadays?  • Kimberly Brown, MD

Maximizing the Donor Potential for Liver Transplant  • James Guarrera, MD

Minimally Invasive vs. Surgical Bariatric Interventions. Winner?  • Kaveh Hajifathalian, MD


Advances in Pancreaticobiliary Endoscopy: Creating Alternate Solutions  • Georgios Papachristou, MDH

Gastroparesis: Are We Moving on This Today?  • Anthony J. Lembo, MD

NASH: Diagnostic and Prognostic Non-Invasive Tests  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA

Irritable Bowel Syndrome: New Management Approaches  • Anthony J. Lembo, MD

Cirrhotic Cardiomyopathy: Does It Exist?  • Marc Klapholz, MD


Liver Cancer: Still on the Rise or Plateaued?  • Nikolaos T. Pyrsopoulos, MD, PhD, MBA

Hepatic Encephalopathy Overview  • Paul Martin, MD

Wilson’s Disease: New Guidelines?  • Nancy Reau, MD

Heartburn/GERD and H. Pylori  • Ronnie Fass, MD

Alcoholic Liver Disease and COVID  • Paul Martin, MD

Hemochromatosis: Is It the Liver’s Heavy Metal?  • Nancy Reau, MD

C Difficult…  • Sahil Khanna, MD

bottom of page